The Asia Pacific Implantable Cardiac Monitors Market would witness market growth of 8.9% CAGR during the forecast period (2018 – 2024).
The implantable cardiac monitor, which is also referred to as implantable loop recorder, is a tiny insertable device used in continuously monitoring hearth rhythms. The device is mostly placed in the left parasternal area of the chest. The device is also placed in some other parts of body, to minimize psychological impact of surgical scar in anterior chest region, without impairing the performance of the device. The implantable cardiac monitors market is witnessing moderated growth owing to the technological advancements in cardiac monitor devices, amplifying demand for implantable cardiac monitors to continuously monitor heart to detect cardiac arrhythmias and atrial fibrillation. Additionally, Favorable reimbursement policies and prominent market players operating in the region are the factors that are further supporting the implantable cardiac monitor market growth.
Based on Indication, the report is segmented into Cardiac Arrhythmias, Atrial Fibrillation and Epilepsy & Unexplained falls. Based on End User, the market is segmented into Hospitals, Ambulatory Surgery centers (ASCs) and Cardiac Center & Clinics. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abiomed, Inc., Abbott Laboratories, Boston Scientific Corporation, Reliant Heart, Inc., Astellas Pharma Inc., Biotronik SE & Co. KG, Agilent Technologies, Inc., Berlin Heart GmbH ,Schiller AG, Jarvik Heart, Inc.
Scope of the Study
Market Segmentation:
By Indication
By End User
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
